在固体脂质纳米粒子和纳米结构脂质载体中的联合封装作为新兴的治疗策略
Joana Torres1,2, Renata Silva1,2,3, Gonçalo Farias4
1UCIBIO, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Molecular diagnosis & therapy
|January 7, 2026
概括
组合疗法使用多种药物,以获得更好的结果和更少的耐药性. 固体脂质纳米粒子 (SLN) 和纳米结构脂质载体 (NLC) 显示出改善组合治疗中药物输送的前景.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 组合疗法通过同时使用多种药物来提高疗效并降低耐药性.
- 组合疗法的挑战包括药物兼容性和生物可用性,特别是难溶药物.
- 像SLN和NLC这样的纳米系统为改善药物输送提供了解决方案.
研究的目的:
- 审查使用SLN和NLC在组合治疗中的联合封装策略的优势.
- 突出SLN和NLC在克服组合治疗挑战中的作用.
- 讨论SLN和NLC在组合治疗的临床转化中的现状和未来前景.
主要方法:
- 关于SLN和NLC在组合治疗中的已发表研究的文献综述.
- 分析基于脂质的纳米系统中联合封装的好处.
- 讨论临床应用的挑战和未来方向.
主要成果:
- 在SLN和NLC中的联合封装增强了药物的稳定性,生物可用性和治疗疗效.
- 这些纳米系统有助于控制药物释放,改善治疗结果.
- SLN和NLC显示出在推进组合治疗方面具有显著的潜力.
结论:
- SLN和NLC是组合治疗的有希望的纳米载体,改善药物输送和疗效.
- 需要进一步的研究,以充分探索SLN和NLC在临床环境中的联合封装的潜力.
- 这些基于脂质的纳米系统是组合治疗中创新的治疗策略的关键领域.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
182
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
182
Bioavailability Enhancement: Drug Solubility Enhancement
210
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
210
Drug Delivery: Overview
714
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
714
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
188
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
188


